A Standardized Asparagus Racemosus Root Extract Improves Hormonal Balance and Menstrual Health and Reduces Vasomotor Symptoms in Perimenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study
Authors:
- 28 May 2025
- journal article
- retracted article
- Published by Taylor & Francis in Journal of the American Nutrition Association
- Vol. 44 (8) , 1-11
Abstract
Perimenopausal women often experience dysmenorrhea, menstrual cramps, hormonal imbalances and vasomotor symptoms (VMS), significantly affecting their quality of life. In Ayurveda, Asparagus racemosus (Shatavari) root extract has been used for female reproductive health. This study evaluated the safety and efficacy of CL22205, a standardized A. racemosus root extract, in managing perimenopausal symptoms. This randomized, double-blind, placebo-controlled trial was conducted on 50 perimenopausal women (age: 40-50 years) experiencing mild to moderate climacteric symptoms. Participants received either CL22205 (200 mg/day) or placebo over a period of 120 consecutive days. Primary outcome measure was Menopausal Rating Scale (MRS) scores. Secondary measures assessed Hot Flash Weekly Weighted Score (HFWWS), Menstrual Symptom Questionnaire (MSQ), ovarian follicular number using ultrasonography, serum Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), Anti-Müllerian Hormone (AMH), and 17β-Estradiol (E2), skin and hair quality, and patient satisfaction using Integrative Medicine Patient Satisfaction & Outcome Scales (IMPSS & IMOS). Serum biochemistry, hematology, and urine analysis were performed for safety evaluation. CL22205 significantly reduced (p < 0.001) total MRS scores and HFWWS vs. placebo and baseline after 120 days of treatment, menstrual symptoms (congestive and spasmodic dysmenorrhea) were improved (p < 0.001). CL22205 decreased serum FSH (56.3%), LH (34.3%), and increased AMH (188.1%, p < 0.001) levels. Skin and hair quality improved significantly (p < 0.001), with no adverse events. CL22205 effectively reduces VMS, menstrual discomfort, and hormonal imbalances while improving skin and hair health, offering a safe and natural alternative for perimenopausal symptoms management.Keywords
This publication has 47 references indexed in Scilit:
- Menopausal Hormone Therapy and Breast Cancer Findings: Clinical Practice ImplicationsCurrent Obstetrics and Gynecology Reports, 2025
- Recent Trends in Menopausal Hormone Therapy Use in the USJAMA Health Forum, 2024
- Exploring pharmacological properties and food applications of Asparagus racemosus (Shatavari)Food Chemistry Advances, 2024
- Adaptogenic property of Asparagus racemosus: Future trends and prospectsHeliyon, 2023
- A role for estrogen in skin ageing and dermal biomechanicsMechanisms of Ageing and Development, 2021
- Prostaglandin level of primary dysmenorrhea pain sufferersEnfermería Clínica, 2020
- Impact of stress on female reproductive health disorders: Possible beneficial effects of shatavari (Asparagus racemosus)Biomedicine & Pharmacotherapy, 2018
- Duration of Menopausal Vasomotor Symptoms Over the Menopause TransitionJAMA Internal Medicine, 2015
- Acne severity grading: Determining essential clinical components and features using a Delphi consensusJournal of the American Academy of Dermatology, 2012
- The development of the menstrual symptom questionnaireBehaviour Research and Therapy, 1975